Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 3, 28 April 2023
Open
Access | Article
Chemical Synthesis of Chiral Drugs
* Author to whom correspondence should be addressed.
Abstract
Chirality exists in most drugs and has a non-negligible impact on the pharmacological activity, metabolic process, and toxicity of drugs in the human body. Drug molecules can only bind to specific receptor molecules in the human body, and the difference in chirality will lead to different structures of drug molecules, which will lead to the inability of drug molecules to bind to receptor molecules, resulting in a decrease in the efficacy of the drug and even adverse effects on the human body. Therefore, the synthesis of correct chiral drugs has always been an area worth exploring. At present, there are two main approaches for the asymmetric synthesis of chiral drugs: chemical synthesis and biosynthesis. This paper explores the application of chemical synthesis to chiral drugs by combining asymmetric organocatalysis with chemical synthesis. In addition, this paper finds that asymmetric organocatalysis is a very worthwhile way to synthesize chiral drugs and has great potential in the development of new drugs.
Keywords
chiral drugs, chemical synthesis, asymmetric organocatalysis, pharmacological activity
References
1. W. Hu and J. Zhou, Chirality, Chiral Drugs and Chiral Synthesis [J]. Chemistry Teaching, 2009 (05),pp. 1.
2. F. Huang, S. Zhuang, W. Liu, L. Lin and L. Sun, Computational investigation on the chiral differentiation of D- and L-penicillamine by β-cyclodextrin. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2021, pp. 248. 2. https://doi.org/10.1016/j. saa.2020.119277. Article 119277.
3. H. Yang and S. You, Asymmetric organic catalysis: a new tool for the synthesis of chiral molecules [J]. Science, 2022, 74(01), pp. 35-38.
4. Y. Zhao, Y. Cao, W. Wang, X. Han, K. Yang, J. Hao, Asymmetric synthesis of fluoxetine enantiomers [J]. Tianjin Chemical Industry, 2003(03), pp. 18-22.
5. Y. Duan and Y. Xuan, Organocatalytic asymmetric synthesis of fluoxetine (English) [J/OL]. Chinese Journal of Medicinal Chemistry, 2022, pp. 2-4. http://kns.cnki .net/kcms/detail/21.1313.R.20220527.1122.002.html
6. M. S. Hoekstra, D. M. Sobieray, M. A. Schwindt, T. A. Mulhern, T. M. Grote, B. K. Huckabee, V. S. Hendrickson, L. C. Franklin, E. J. Granger, G. L. Karrick, Chemical Development of CI-1008, an Enantiomerically Pure Anticonvulsant. Org. Process Res. Dev. 1997, pp. 1, 26−38.
7. M. J. Burk, P. D.de Koning, T. M.Grote, M. S.Hoekstra, G. Hoge, R. A. Jennings, W. S. Kissel, T. V. Le, I. C. Lennon, T. Mulhern, J. A. Ramsden, R. A. Wade, An enantioselective synthesis of (S)-(+)-3-aminomethyl-5-methylhexanoic acid via asymmetric hydrogenation. J. Org. Chem. 2003, pp. 68, 5731−5734. (b) Hoge, G.; Wu, H.-P.; Kissel, W. S.; Pflum, D. A.; Greene, D. J.; Bao, J. Highly selective asymmetric hydrogenation using a three hindered quadrant bisphosphine rhodium catalyst. J. Am. Chem. Soc. 2004, 126, 5966−5967.
8. A. Carlone; L. Bernardi; P. McCormack; T. Warr; S. Oruganti; C.J. Cobley. Asymmetric Organocatalysis and Continuous Chemistry for an Efficient and Cost-Competitive Process to Pregabalin. Org. Process Res. 2021, pp. 2795–2804.
9. B. Zhang, E. Zhang, W. Wang, Y. Guo, H. Liu, Organocatalytic asymmetric synthesis of the drug dapoxetine for the treatment of premature ejaculation [C] 2011 National Conference on Medicinal Chemistry - Abstract Collection of Innovative Papers at the Source of Drugs. 2011, pp. 452.
10. S. Wang, Y. Jiang, S. Wu, G. Dong, Z. Miao, W. Zhang, C. Sheng, Meeting Organocatalysis with Drug Discovery: Asymmetric Synthesis of 3,3′-Spirooxindoles Fused with Tetrahydrothiopyrans as Novel p53-MDM2 Inhibitors. Org. Lett. 2016, 18, 1028-1031.
11. Y. Li, Q. Feng, X. Zhang, Y. Wang, M. Zhao, Asymmetric Organocatalysis: Simplifying the Complex to Help Drug Discovery - 2021 Nobel Prize in Chemistry [J]. Journal of Capital Medical University, 2021, 42(05): 883-887.
12. The Nobel Prize. The Nobel Prize in Chemistry 2021 [EB/ OL]. 2021-10-06. https: / /www. Nobel-prize. org /prizes/chemistry /2021 /summary /.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Biological Engineering and Medical Science (ICBioMed 2022), Part I
- ISBN (Print)
- 978-1-915371-25-6
- ISBN (Online)
- 978-1-915371-26-3
- Published Date
- 28 April 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/3/20220209
- Copyright
- 28 April 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited